Clin2
NCT06853912Possibly a fitActive, not recruiting

Psilocybin therapy for PTSD and alcohol use in veterans and first responders

Alcohol Use Disorder (AUD)PTSD

Treatments studied

Part of Mental health clinical trials.

This trial tests whether psilocybin, given along with psychological support, can help military veterans and first responders who have both PTSD and alcohol use disorder. If you're a veteran or first responder looking to reduce or stop drinking, you may be able to participate.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • You are a US military veteran or a first responder (EMT, paramedic, firefighter, or law enforcement officer).
  • You are between 21 and 65 years old.
  • You have both PTSD and alcohol use disorder, as diagnosed by a doctor.
  • You want to cut back or stop drinking and are willing to not drink for one week before the study drug session.
  • You have a friend or family member who can pick you up after the session and stay with you overnight.
  • You must be able to come to the University of Washington for in-person visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico
NCT06888128Recruiting· Phase 2
Psilocybin for PTSD in veterans

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Houston, Texas
NCT07405606Not yet recruiting· Phase 2
Psilocybin therapy for depression and alcohol use disorder

This study tests whether a drug called psilocybin, given along with therapy, can help people who have both major depression and alcohol use disorder. You may be a good fit if you have tried other treatments or don't want to start new medications.

Toronto, Ontario
NCT06580444Not yet recruiting· Phase 2
Study of brexanolone for PTSD and alcohol use in veterans

This trial tests if a drug called brexanolone can help veterans with both PTSD and alcohol use disorder. You will be asked about your drinking and PTSD symptoms, and may receive the drug in a lab setting.

NCT07332143Not yet recruiting· Phase 2
Psilocybin therapy for PTSD in Georgia veterans

This trial tests whether a drug called psilocybin, combined with therapy, can help treat PTSD. It is for Georgia military members and veterans who have had PTSD for at least 6 months.

Atlanta, Georgia
NCT06386003Recruiting· Phase 2
Psilocybin and talk therapy for chronic PTSD

This trial tests whether a medication called psilocybin (the active ingredient in magic mushrooms) can help people with long-term PTSD when combined with a specific type of talk therapy. The goal is to see if this approach reduces PTSD symptoms more than therapy alone.

Toronto, Ontario

Hear when a new Alcohol Use Disorder (AUD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.